Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Completed 4Unknown 2No longer available 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Basal Cell 2Skin Diseases 1Neoplasms, Basal Cell 1Keratosis, Actinic 1Connective Tissue Diseases 1

Interventions

Tomography, Optical Coherence 3Biopsy 3methyl 5-aminolevulinate 2daromun 2Mohs Surgery 2Imiquimod 2Aminolevulinic Acid 2Watchful Waiting 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Solutions 1Patient Reported Outcome Measures 1Nivolumab 1Niacinamide 1Methylation 1Itraconazole 1Immunologic Factors 1Hydrogen Peroxide 1Glatiramer Acetate 1Fluorouracil 1Electroporation 1Dermoscopy 1Curettage 1Cryotherapy 1Coat Protein Complex I 1Cautery 1Capecitabine 1Calcium Chloride 1BF-200 ALA 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Basal Cell × methyl 5-aminolevulinate × Clear all
NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Unknown
117 enrolled
Dermatologic

Carcinoma, Basal Cell, Neoplasms, Basal Cell

NCT01491711 2014-01-31

Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

Maastricht University Medical Center

Phase 4 Unknown
162 enrolled
Dermatologic

Carcinoma, Basal Cell, Connective Tissue Diseases, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡